TTNP
Titan Pharmaceuticals
TTNP
TTNP
Delisted
TTNP was delisted on the 1st of October, 2025.
18 hedge funds and large institutions have $498K invested in Titan Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
21% less capital invested
Capital invested by funds: $633K → $498K (-$135K)
Holders
18
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$28.9K | |
| 2 | +$11.2K | |
| 3 | +$9.34K | |
| 4 |
Renaissance Technologies
New York
|
+$47 |
| 5 |
JP Morgan Chase
New York
|
+$46 |
Top Sellers
| 1 | -$19.2K | |
| 2 | -$45 | |
| 3 | -$3 | |
| 4 |
CSC
Caldwell Sutter Capital
Sausalito,
California
|
-$1 |
| 5 |
DJSG
D.J. St. Germain
Springfield,
Massachusetts
|
-$1 |